The latest article about Clarity Pharmaceuticals is in September’s Nature Biotechnology. Please contact us if you have any queries or interest in this area of radiopharmaceutical development.
“Using positron emission tomography to visualize the distribution of a drug candidate in the entire body, Clarity Pharmaceuticals helps biopharmaceutical companies spend their money wisely on the most promising products in their preclinical pipelines.”
Read the full article here:
Clarity uses a cutting-edge imaging technique to guide drug development
